comparemela.com

Latest Breaking News On - Committee for human medical products - Page 1 : comparemela.com

Why Dynavax Stock Blasted 16% Higher Today

Dante Labs Partnering with The Renato Dulbecco Foundation to advance personalized medicines for cancer, COVID-19 and rare diseases

NEW YORK, Feb. 18, 2022, a global leader in genomics and precision medicine, today announced it has partnered with The Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases

Investegate |Dante Labs Announcements | Dante Labs: Dante Labs Partnering with The Renato Dulbecco Foundation to advance personalized medicines for cancer, COVID-19 and rare diseases

Celltrion set to win EC approval for biosimilar to Humira medicine

Celltrion set to win EC approval for biosimilar to Humira medicine Posted : 2020-12-11 12:41 Updated : 2020-12-11 17:18 Celltrion scientists work on a Humira biosimilar medicine at the company s research center in Songdo, Incheon. / Courtesy of Celltrion By Kim Hyun-bin Celltrion received a sales approval recommendation from the European Medicine Agency (EMA) for its CT-P17 drug, Thursday local time. The recommendation came from the EMA s Committee for Human Medical Products (CHMP). CHMP is an organization within the EMA that conducts scientific evaluation of a new medicine and submits an approval recommendation. This is practically considered a sales approval. CT-P17 is a biosimilar of Humira and used to treat a range of illnesses, including rheumatoid arthritis. It will become the first of the high-level Humira biosimilar drugs to be introduced in the European market.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.